Yun-Hsuan Lee

1.7k total citations
32 papers, 1.1k citations indexed

About

Yun-Hsuan Lee is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yun-Hsuan Lee has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 27 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Yun-Hsuan Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers). Yun-Hsuan Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (27 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers). Yun-Hsuan Lee collaborates with scholars based in Taiwan, United States and Canada. Yun-Hsuan Lee's co-authors include Teh‐Ia Huo, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yi‐Hsiang Huang, Han‐Chieh Lin, Po‐Hong Liu, Yi‐You Chiou, Chien‐Wei Su, Fa‐Yauh Lee and Rheun‐Chuan Lee and has published in prestigious journals such as PLoS ONE, Hepatology and Annals of Surgery.

In The Last Decade

Yun-Hsuan Lee

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yun-Hsuan Lee Taiwan	18	989	701	340	233	172	32	1.1k
Ya-Hao Zhou China	15	710 0.7×	415 0.6×	258 0.8×	226 1.0×	199 1.2×	44	931
Yi‐You Chiou Taiwan	21	1.3k 1.3×	939 1.3×	513 1.5×	249 1.1×	221 1.3×	49	1.6k
Kazuya Kariyama Japan	17	679 0.7×	451 0.6×	188 0.6×	143 0.6×	172 1.0×	57	981
Tianfu Wen China	18	567 0.6×	301 0.4×	279 0.8×	189 0.8×	165 1.0×	56	759
Brian Shrager United States	8	547 0.6×	265 0.4×	339 1.0×	213 0.9×	165 1.0×	11	904
M. Giovanelli Italy	8	543 0.5×	293 0.4×	287 0.8×	173 0.7×	159 0.9×	11	825
Valentina Santi Italy	11	883 0.9×	789 1.1×	190 0.6×	85 0.4×	110 0.6×	23	1.0k
Hedayat Bouzari Italy	14	879 0.9×	506 0.7×	470 1.4×	101 0.4×	312 1.8×	22	1.1k
Vikki Tang China	8	564 0.6×	311 0.4×	197 0.6×	109 0.5×	183 1.1×	20	711
Hirokazu Chishina Japan	18	900 0.9×	378 0.5×	199 0.6×	163 0.7×	225 1.3×	44	1.1k

Countries citing papers authored by Yun-Hsuan Lee

Since Specialization

Citations

This map shows the geographic impact of Yun-Hsuan Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun-Hsuan Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun-Hsuan Lee more than expected).

Fields of papers citing papers by Yun-Hsuan Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun-Hsuan Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun-Hsuan Lee. The network helps show where Yun-Hsuan Lee may publish in the future.

Co-authorship network of co-authors of Yun-Hsuan Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yun-Hsuan Lee. A scholar is included among the top collaborators of Yun-Hsuan Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun-Hsuan Lee. Yun-Hsuan Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Po‐Hong, Cheng‐Yuan Hsia, Yun-Hsuan Lee, et al.. (2018). Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma. BMC Cancer. 18(1). 289–289. 12 indexed citations

Ho, Shu‐Yein, Po‐Hong Liu, Chia‐Yang Hsu, et al.. (2018). Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection. Scientific Reports. 8(1). 4773–4773. 32 indexed citations

Ho, Shu‐Yein, Po‐Hong Liu, Chia‐Yang Hsu, et al.. (2018). Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Scientific Reports. 8(1). 15074–15074. 14 indexed citations

Ho, Shu‐Yein, Po‐Hong Liu, Chia‐Yang Hsu, et al.. (2018). Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Scientific Reports. 8(1). 843–843. 27 indexed citations

Ho, Shu‐Yein, Po‐Hong Liu, Chia‐Yang Hsu, et al.. (2017). Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. PLoS ONE. 12(7). e0180408–e0180408. 33 indexed citations

Hsu, Chia‐Yang, Po‐Hong Liu, Shu‐Yein Ho, et al.. (2017). Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study. PLoS ONE. 12(11). e0188031–e0188031. 9 indexed citations

Liu, Po‐Hong, Chien‐Wei Su, Chia‐Yang Hsu, et al.. (2016). Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy. PLoS ONE. 11(5). e0155588–e0155588. 43 indexed citations

Liu, Po‐Hong, Chia‐Yang Hsu, Cheng‐Yuan Hsia, et al.. (2016). Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients. European Journal of Cancer. 63. 25–33. 30 indexed citations

Hsu, Chia‐Yang, Po‐Hong Liu, Yun-Hsuan Lee, et al.. (2015). Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System. Medicine. 94(29). e1223–e1223. 12 indexed citations

10.

Liu, Po‐Hong, Chia‐Yang Hsu, Cheng‐Yuan Hsia, et al.. (2015). Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. Journal of Hepatology. 64(3). 601–608. 184 indexed citations

11.

Hsu, Chia‐Yang, Po‐Hong Liu, Cheng‐Yuan Hsia, et al.. (2015). Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study. Annals of Surgical Oncology. 23(3). 994–1002. 36 indexed citations

12.

Liu, Po‐Hong, Chia‐Yang Hsu, Yun-Hsuan Lee, et al.. (2014). Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma. Medicine. 93(28). e264–e264. 20 indexed citations

13.

Lee, Yun-Hsuan, Chia‐Yang Hsu, Po‐Hong Liu, et al.. (2014). Radiofrequency Ablation is Better Than Surgical Resection in Patients With Hepatocellular Carcinoma Within the Milan Criteria and Preserved Liver Function. Journal of Clinical Gastroenterology. 49(3). 242–249. 30 indexed citations

14.

Liu, Po‐Hong, Yun-Hsuan Lee, Chia‐Yang Hsu, et al.. (2014). Survival Advantage of Radiofrequency Ablation Over Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Good Performance Status Within the Milan Criteria. Annals of Surgical Oncology. 21(12). 3835–3843. 16 indexed citations

15.

Vitale, Alessandro, Alessandro Cucchetti, Yun-Hsuan Lee, et al.. (2014). Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score. Annals of Surgical Oncology. 22(6). 1901–1907. 35 indexed citations

16.

Liu, Po‐Hong, Yun-Hsuan Lee, Cheng‐Yuan Hsia, et al.. (2014). Surgical Resection Versus Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis. Annals of Surgical Oncology. 21(6). 1825–1833. 90 indexed citations

17.

Hsu, Chia‐Yang, Yun-Hsuan Lee, Cheng‐Yuan Hsia, et al.. (2013). Performance Status Enhances the Selection of Treatment for Patients with Hepatocellular Carcinoma Within the Milan Criteria. Annals of Surgical Oncology. 20(6). 2035–2042. 13 indexed citations

18.

Lee, Yun-Hsuan, Chia‐Yang Hsu, Yi‐Hsiang Huang, et al.. (2012). α-Fetoprotein-to-Total Tumor Volume Ratio Predicts Post-operative Tumor Recurrence in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 17(4). 730–738. 22 indexed citations

19.

Lee, Yun-Hsuan, Chia‐Yang Hsu, Cheng‐Yuan Hsia, et al.. (2012). Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems. Digestive and Liver Disease. 44(10). 868–874. 9 indexed citations

20.

Lee, Yun-Hsuan, Chia‐Yang Hsu, Cheng‐Yuan Hsia, et al.. (2012). Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma. Hepatology International. 7(2). 645–654. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact